Securian Asset Management Inc. Sells 667 Shares of Healthpeak Properties, Inc. $DOC

Securian Asset Management Inc. trimmed its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 1.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,304 shares of the real estate investment trust’s stock after selling 667 shares during the quarter. Securian Asset Management Inc.’s holdings in Healthpeak Properties were worth $636,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Invesco Ltd. boosted its position in Healthpeak Properties by 20.7% during the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock worth $467,311,000 after purchasing an additional 3,967,830 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in Healthpeak Properties by 6.5% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 18,397,841 shares of the real estate investment trust’s stock worth $372,004,000 after purchasing an additional 1,129,924 shares during the period. Centersquare Investment Management LLC boosted its position in Healthpeak Properties by 18.5% during the first quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust’s stock worth $268,642,000 after purchasing an additional 2,070,416 shares during the period. Dimensional Fund Advisors LP boosted its position in Healthpeak Properties by 0.7% during the first quarter. Dimensional Fund Advisors LP now owns 10,392,052 shares of the real estate investment trust’s stock worth $210,126,000 after purchasing an additional 76,978 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in Healthpeak Properties by 0.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 10,238,001 shares of the real estate investment trust’s stock worth $207,012,000 after purchasing an additional 84,551 shares during the period. 93.57% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Scott M. Brinker acquired 1,490 shares of the business’s stock in a transaction that occurred on Monday, August 4th. The stock was acquired at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the transaction, the chief executive officer directly owned 211,906 shares of the company’s stock, valued at $3,566,377.98. This trade represents a 0.71% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have bought a total of 8,783 shares of company stock worth $150,129 over the last three months. Corporate insiders own 0.23% of the company’s stock.

Healthpeak Properties Trading Up 1.1%

Shares of Healthpeak Properties stock opened at $18.75 on Friday. The firm has a 50-day moving average of $18.32 and a 200-day moving average of $17.91. The stock has a market cap of $13.03 billion, a PE ratio of -374.95, a PEG ratio of 3.16 and a beta of 1.09. Healthpeak Properties, Inc. has a 52-week low of $16.63 and a 52-week high of $23.12. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.43%. The business had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. During the same quarter in the prior year, the business posted $0.45 earnings per share. Healthpeak Properties’s revenue was up .8% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, December 19th. This represents a c) annualized dividend and a yield of 6.5%. Healthpeak Properties’s dividend payout ratio is currently 508.33%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on DOC shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Healthpeak Properties in a research report on Friday. Scotiabank cut shares of Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and reduced their target price for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Robert W. Baird set a $21.00 target price on shares of Healthpeak Properties and gave the company an “outperform” rating in a research report on Wednesday, July 30th. Wall Street Zen cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Monday, July 7th. Finally, Cantor Fitzgerald initiated coverage on shares of Healthpeak Properties in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 target price for the company. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $21.33.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.